CAS 359714-55-9

Formule : C18H17N3O5

InChI : InChI=1S/C18H17N3O5/c1-12-10-14(21-18(23)26-17(20-21)24-2)8-9-15(12)19-16(22)25-11-13-6-4-3-5-7-13/h3-10H,11H2,1-2H3,(H,19,22)

Code InChI : QTENHWTVRQKWRI-UHFFFAOYSA-N

SMILES : CC1=C(C=CC(=C1)N2C(=O)OC(=N2)OC)NC(=O)OCC3=CC=CC=C3

CAY10499

CAS : 359714-55-9

Degré de pureté : 99.90%

Ref: IN-DA00C0W9

MAGL-IN-5

CAS : 359714-55-9

MAGL-IN-5

Formule : C₁₈H₁₇N₃O₅

Degré de pureté : ≥98%

Masse moléculaire : 355.34

Ref: 54-BUP05870

MAGL-IN-5

CAS : 359714-55-9

MAGL-IN-5 is a non-selective lipase inhibitor.

Formule : C₁₈H₁₇N₃O₅

Degré de pureté : 99.73%

Couleur et forme : White Solid

Masse moléculaire : 355.34

Ref: TM-T9967

CAY10499

CAS : 359714-55-9

Benzyl N-[4-(5-methoxy-2-oxo-1,3,4-oxadiazol-3-yl)-2-methylphenyl]carbamate is an uncoupling agent that is used to treat obesity. It is a beige powder that has been shown to increase the rate of fat burning in animal studies. This drug also causes weight loss by increasing the body's energy expenditure, especially in tissues such as adipose and muscle tissue. The cellular uptake of this drug has been studied using multilocular cells from women. Benzyl N-[4-(5-methoxy-2-oxo-1,3,4-oxadiazol-3-yl)-2-methylphenyl]carbamate may have potential applications as a marker for estrogen levels in women.

Formule : C₁₈H₁₇N₃O₅

Degré de pureté : Min. 95%

Masse moléculaire : 355.3 g/mol

Ref: 3D-JPA71455